Scientific  ||| S:0 E:11 ||| JJ
controversies  ||| S:11 E:25 ||| NNS
in  ||| S:25 E:28 ||| IN
Brazilian  ||| S:28 E:38 ||| JJ
television  ||| S:38 E:49 ||| NN
journalism ||| S:49 E:59 ||| NN
:  ||| S:59 E:61 ||| :
the  ||| S:61 E:65 ||| DT
coverage  ||| S:65 E:74 ||| NN
of  ||| S:74 E:77 ||| IN
stem  ||| S:77 E:82 ||| JJ
cell  ||| S:82 E:87 ||| NN
research  ||| S:87 E:96 ||| NN
onJornal  ||| S:96 E:105 ||| NNP
Nacional  ||| S:105 E:114 ||| NNP
In  ||| S:114 E:117 ||| IN
1998 ||| S:117 E:121 ||| CD
,  ||| S:121 E:123 ||| ,
stem  ||| S:123 E:128 ||| JJ
cell  ||| S:128 E:133 ||| NN
research  ||| S:133 E:142 ||| NN
became  ||| S:142 E:149 ||| VBD
a  ||| S:149 E:151 ||| DT
subject  ||| S:151 E:159 ||| NN
of  ||| S:159 E:162 ||| IN
heightened  ||| S:162 E:173 ||| JJ
controversy ||| S:173 E:184 ||| NN
.  ||| S:184 E:186 ||| .
In  ||| S:186 E:189 ||| IN
Brazil ||| S:189 E:195 ||| NNP
,  ||| S:195 E:197 ||| ,
the  ||| S:197 E:201 ||| DT
polemic  ||| S:201 E:209 ||| NN
came  ||| S:209 E:214 ||| VBD
to  ||| S:214 E:217 ||| TO
a  ||| S:217 E:219 ||| DT
head  ||| S:219 E:224 ||| NN
in  ||| S:224 E:227 ||| IN
2008  ||| S:227 E:232 ||| CD
when  ||| S:232 E:237 ||| WRB
the  ||| S:237 E:241 ||| DT
Federal  ||| S:241 E:249 ||| NNP
Supreme  ||| S:249 E:257 ||| NNP
Court  ||| S:257 E:263 ||| NNP
commenced  ||| S:263 E:273 ||| VBD
a  ||| S:273 E:275 ||| DT
judicial  ||| S:275 E:284 ||| JJ
review  ||| S:284 E:291 ||| NN
of  ||| S:291 E:294 ||| IN
the  ||| S:294 E:298 ||| DT
new  ||| S:298 E:302 ||| JJ
Biosecurity  ||| S:302 E:314 ||| NNP
Law  ||| S:314 E:318 ||| NNP
because  ||| S:318 E:326 ||| IN
it  ||| S:326 E:329 ||| PRP
permitted  ||| S:329 E:339 ||| VBD
the  ||| S:339 E:343 ||| DT
use  ||| S:343 E:347 ||| NN
of  ||| S:347 E:350 ||| IN
human  ||| S:350 E:356 ||| JJ
embryos  ||| S:356 E:364 ||| NN
in  ||| S:364 E:367 ||| IN
research ||| S:367 E:375 ||| NN
.  ||| S:375 E:377 ||| .
This  ||| S:377 E:382 ||| DT
study  ||| S:382 E:388 ||| NN
analyzes  ||| S:388 E:397 ||| VBD
the  ||| S:397 E:401 ||| DT
coverage  ||| S:401 E:410 ||| NN
of  ||| S:410 E:413 ||| IN
human  ||| S:413 E:419 ||| JJ
embryonic  ||| S:419 E:429 ||| NNS
stem  ||| S:429 E:434 ||| VBP
cell  ||| S:434 E:439 ||| NN
research  ||| S:439 E:448 ||| NN
on  ||| S:448 E:451 ||| IN
the  ||| S:451 E:455 ||| DT
national  ||| S:455 E:464 ||| JJ
daily  ||| S:464 E:470 ||| JJ
evening  ||| S:470 E:478 ||| NN
news  ||| S:478 E:483 ||| NN
show ||| S:483 E:487 ||| NN
,  ||| S:487 E:489 ||| ,
Jornal  ||| S:489 E:496 ||| NNP
Nacional  ||| S:496 E:505 ||| NNP
.  ||| S:505 E:507 ||| .
A  ||| S:507 E:509 ||| DT
positive  ||| S:509 E:518 ||| JJ
tone  ||| S:518 E:523 ||| NN
is  ||| S:523 E:526 ||| VBZ
observed ||| S:526 E:534 ||| VBN
,  ||| S:534 E:536 ||| ,
marked  ||| S:536 E:543 ||| VBD
by  ||| S:543 E:546 ||| IN
a  ||| S:546 E:548 ||| DT
focus  ||| S:548 E:554 ||| NN
on  ||| S:554 E:557 ||| IN
the  ||| S:557 E:561 ||| DT
potential  ||| S:561 E:571 ||| JJ
benefits  ||| S:571 E:580 ||| NNS
of  ||| S:580 E:583 ||| IN
the  ||| S:583 E:587 ||| DT
research  ||| S:587 E:596 ||| NN
and  ||| S:596 E:600 ||| CC
omission  ||| S:600 E:609 ||| NN
of  ||| S:609 E:612 ||| IN
its  ||| S:612 E:616 ||| PRP$
limitations  ||| S:616 E:628 ||| NNS
and  ||| S:628 E:632 ||| CC
risks ||| S:632 E:637 ||| NNS
.  ||| S:637 E:639 ||| .
The  ||| S:639 E:643 ||| DT
limited  ||| S:643 E:651 ||| JJ
success  ||| S:651 E:659 ||| NN
rate  ||| S:659 E:664 ||| NN
thus  ||| S:664 E:669 ||| RB
far  ||| S:669 E:673 ||| RB
obtained  ||| S:673 E:682 ||| VBN
from  ||| S:682 E:687 ||| IN
embryonic  ||| S:687 E:697 ||| JJ
stem  ||| S:697 E:702 ||| NN
cell  ||| S:702 E:707 ||| NN
research  ||| S:707 E:716 ||| NN
and  ||| S:716 E:720 ||| CC
the  ||| S:720 E:724 ||| DT
risks  ||| S:724 E:730 ||| NNS
of  ||| S:730 E:733 ||| IN
inducing  ||| S:733 E:742 ||| VBG
the  ||| S:742 E:746 ||| DT
formation  ||| S:746 E:756 ||| NN
of  ||| S:756 E:759 ||| IN
tumors  ||| S:759 E:766 ||| NNS
were  ||| S:766 E:771 ||| VBD
omitted ||| S:771 E:778 ||| VBN
,  ||| S:778 E:780 ||| ,
intimating  ||| S:780 E:791 ||| VBG
that  ||| S:791 E:796 ||| IN
the  ||| S:796 E:800 ||| DT
only  ||| S:800 E:805 ||| JJ
barrier  ||| S:805 E:813 ||| NN
to  ||| S:813 E:816 ||| TO
new  ||| S:816 E:820 ||| JJ
treatments  ||| S:820 E:831 ||| NNS
and  ||| S:831 E:835 ||| CC
cures  ||| S:835 E:841 ||| NNS
was  ||| S:841 E:845 ||| VBD
the  ||| S:845 E:849 ||| DT
legislation ||| S:849 E:860 ||| NN
.  ||| S:860 E:862 ||| .
